Targeting the Endocannabinoid System May Help Social Withdrawal in Schizophrenia
A drug that boosts endocannabinoid levels reversed social withdrawal in a rat model of schizophrenia, with the insular cortex identified as a key brain region.
Quick Facts
What This Study Found
The FAAH inhibitor URB597 reversed social withdrawal in PCP-treated rats (a schizophrenia model) but decreased social interaction in healthy controls. The agranular insular cortex emerged as a key neural substrate — pCREB levels in this region positively correlated with social interaction time (r=0.43).
Key Numbers
Six cortical regions analyzed. Agranular insular cortex pCREB correlated with social interaction (r=0.43, p<0.05). URB597 reversed social deficits in PCP-treated rats but reduced social behavior in healthy controls, showing state-dependent effects.
How They Did This
Rats were treated with PCP (schizophrenia model) or saline, then received FAAH inhibitor URB597 or vehicle. Social interaction was measured, and CREB/pCREB expression was analyzed in six prefrontal and insular cortical regions using immunohistochemistry.
Why This Research Matters
Social withdrawal is one of the most debilitating symptoms of schizophrenia and has no effective treatment. This study identifies both a therapeutic target (endocannabinoid system) and a brain region (insular cortex) that could guide drug development.
The Bigger Picture
The negative symptoms of schizophrenia — social withdrawal, flat affect, lack of motivation — remain the greatest unmet need in psychiatry. The endocannabinoid system's state-dependent effects (helping when impaired, not when normal) make it an unusually promising target.
What This Study Doesn't Tell Us
PCP model captures some but not all aspects of schizophrenia. Small sample sizes limit statistical power. Single-dose acute treatment — chronic effects unknown. Rat social behavior is a limited proxy for human social functioning.
Questions This Raises
- ?Why does URB597 improve social behavior in the disease state but worsen it in healthy animals?
- ?Could FAAH inhibitors be developed specifically for schizophrenia's negative symptoms?
- ?What role does the insular cortex play in human social withdrawal?
Trust & Context
- Key Stat:
- Evidence Grade:
- Single preclinical study with small sample sizes provides mechanistic insights but requires replication and clinical translation.
- Study Age:
- Published 2026, contributing to growing endocannabinoid-schizophrenia research.
- Original Title:
- Inhibition of Fatty Acid Amide Hydrolase Alters Cortical CREB Signaling and Social Behavior in a Rat Model of Schizophrenia.
- Published In:
- The European journal of neuroscience, 63(3), e70427 (2026)
- Authors:
- Kumar, Aditya, Seillier, Lenka, Kuchař, Martin(2), Seillier, Alexandre
- Database ID:
- RTHC-08404
Evidence Hierarchy
Frequently Asked Questions
Could cannabis-related drugs help with schizophrenia symptoms?
A drug that boosts the body's own endocannabinoids (by blocking the enzyme FAAH) reversed social withdrawal in a rat model of schizophrenia — but importantly, this is not about cannabis itself, and cannabis use is generally not recommended for people with schizophrenia.
Why did the drug work differently in healthy vs. sick animals?
URB597 improved social behavior in schizophrenia-model rats but actually reduced it in healthy rats, suggesting the endocannabinoid system has different roles depending on brain state — which could allow targeted treatment of specific symptoms.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- cannabis-and-relationships-complete-guide
- cannabis-culture-and-lifestyle-guide
- why-more-or-less-social-on-thc
- thc-and-antipsychotics-complicated-relationship
- cannabis-and-socializing-only-use-around-others
Cite This Study
https://rethinkthc.com/research/RTHC-08404APA
Kumar, Aditya; Seillier, Lenka; Kuchař, Martin; Seillier, Alexandre. (2026). Inhibition of Fatty Acid Amide Hydrolase Alters Cortical CREB Signaling and Social Behavior in a Rat Model of Schizophrenia.. The European journal of neuroscience, 63(3), e70427. https://doi.org/10.1111/ejn.70427
MLA
Kumar, Aditya, et al. "Inhibition of Fatty Acid Amide Hydrolase Alters Cortical CREB Signaling and Social Behavior in a Rat Model of Schizophrenia.." The European journal of neuroscience, 2026. https://doi.org/10.1111/ejn.70427
RethinkTHC
RethinkTHC Research Database. "Inhibition of Fatty Acid Amide Hydrolase Alters Cortical CRE..." RTHC-08404. Retrieved from https://rethinkthc.com/research/kumar-2026-inhibition-of-fatty-acid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.